Fibromuscular dysplasia epidemiology and demographics

Jump to navigation Jump to search

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia epidemiology and demographics

CDC on Fibromuscular dysplasia epidemiology and demographics

Fibromuscular dysplasia epidemiology and demographics in the news

Blogs on Fibromuscular dysplasia epidemiology and demographics

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.

Overview

The prevalence of FMD in the general population is not known. In some studies, the prevalence of renal artery FMD has been calculated to be approximately 4 per 100 adults.. Patients of all age groups may develop FMD, but women are more commonly affected by FMD than men. The women to men ratio is approximately 9:1.5.

Epidemiology and Demographics

Prevalence

  • The prevalence of FMD in the general population is not known; however, the prevalence of renal artery FMD has been estimated to be as high as 4 per 100 adults.[1][2]
  • In one of the largest series of >1000 patients with FMD, 58% had involvement the renal artery, 32% involved the extracranial cerebrovascular arteries and 10% involved other arterial territories such as the visceral arteries or external iliac arteries. Approximately 70% of patients have multiple arteries involvement.[3]


  • Among patients with renovascular hypertension, FMD accounts for 35 to 50 percent of cases in children and 5 to 10 percent of cases in adults under the age of 60 years.
  • Extracranial cerebrovascular (eg, carotid and vertebral arteries) involvement is common in patients with established renal FMD. Data from the first 447 patients entered into the United States FMD Registry reveal that approximately 65 percent have extracranial cerebrovascular disease When cerebrovascular disease is present, there is often bilateral carotid involvement, coexisting vertebral artery disease, and, less commonly, disease in the external carotid, middle cerebral, anterior cerebral, basilar, and anterior communicating arteries. FMD may also be associated with intracranial aneurysms.

Age

  • Patients of all age groups may develop FMD.
  • The mean age at diagnosis of the first 447 patients enrolled in the U.S. Registry for FMD was 51.9 ± 13.1 years (range of 5 to 86 years),

Gender

  • Women are more commonly affected by FMD than men. The women to men ratio is approximately 9:1.5.
  • In the US Registry, 91%of registrants were female.

References

  1. Cragg AH, Smith TP, Thompson BH, Maroney TP, Stanson AW, Shaw GT, Hunter DW, Cochran ST. Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. Radiology. 1989;172:145–147
  2. Perdu, J; Boutouyrie, P; Bourgain, C; Stern, N; Laloux, B; Bozec, E; Azizi, M; Bonaiti-Pellié, C; Plouin, P-F; Laurent, S; Gimenez-Roqueplo, A-P; Jeunemaitre, X (2007). "Inheritance of arterial lesions in renal fibromuscular dysplasia". Journal of Human Hypertension. 21 (5): 393–400. ISSN 0950-9240. doi:10.1038/sj.jhh.1002156
  3. Olin, J. W.; Gornik, H. L.; Bacharach, J. M.; Biller, J.; Fine, L. J.; Gray, B. H.; Gray, W. A.; Gupta, R.; Hamburg, N. M.; Katzen, B. T.; Lookstein, R. A.; Lumsden, A. B.; Newburger, J. W.; Rundek, T.; Sperati, C. J.; Stanley, J. C. (2014). "Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions: A Scientific Statement From the American Heart Association". Circulation. 129 (9): 1048–1078. doi:10.1161/01.cir.0000442577.96802.8c. ISSN 0009-7322.

Template:WH Template:WS